Case Study: Sanofi improves influenza vaccination rates in people living with diabetes with Evidation's digital intervention

Sanofi boosts flu vaccination rates by 3.1% with Evidation

Evidation partnered with Sanofi to address the challenge of low influenza vaccination rates among people living with diabetes, a population at high risk for serious complications. Less than two-thirds of this group were receiving the annual vaccine, creating a significant public health concern.

Evidation implemented a digitally administered intervention, delivering personalized monthly messages through an online health platform. This solution provided educational content, vaccine location information, and incentive points. The study resulted in a statistically significant increase in vaccination rates, with 64.2% of the intervention group getting vaccinated compared to 61.1% in the control group, demonstrating Evidation's effective approach to driving meaningful behavioral change.

Sanofi